|
🐜
|
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
102 auth.
S. Qin,
S. Chan,
S. Gu,
Y. Bai,
Z. Ren,
Xiaoyan Lin,
Zhendong Chen,
W. Jia,
Yongdong Jin,
Ya-bing Guo,
Xiaohua Hu,
Z. Meng,
Jun Liang,
Ying Cheng,
Jianping Xiong,
...
H. Ren,
Fan Yang,
W. Li,
Yajin Chen,
Yong Zeng,
A. Sultanbaev,
M. Pazgan-Simon,
M. Pisetska,
D. Melisi,
Dmitriy Ponomarenko,
Yurii Osypchuk,
I. Sinielnikov,
Tsai‐Sheng Yang,
Xiao Liang,
Chunxia Chen,
Linna Wang,
A. Cheng,
A. Kaseb,
A. Vogel,
Mingxiang Zhang,
Li Xu,
Xianglin Yuan,
Da Li,
Jierer Ying,
Jingdong Zhang,
Tao Zhang,
K. Gu,
Yifu He,
Ping Hao,
D. Jiang,
Shu Zhang,
B. Xing,
Baihong Zhang,
Dong Wang,
Xiaofeng Zhai,
Houjie Liang,
B. Cybulska-Stopa,
M. Dvorkin,
D. Stroyakovskiy,
M. Nechaeva,
C. Yen,
W. Su,
Yen Chen,
I. Bondarenko,
Lin Yang,
W. Fang,
C. Gómez-Martín,
M. Ryu,
Han-Sang Kim,
Jee-Hyun Kim,
Oleg Zarubenkov,
R. Orlova,
E. Poddubskaya,
N. Fadeeva,
Y. Makarova,
Y. Chao,
Chao-Hung Hung,
Maryna Neffa,
O. Vynnychenko,
Adam M. Burgoyne,
C. Hao,
R. Mohr,
R. Diaz-Beveridge,
Jaime Feliú-Batlle,
Antonio Cubillo-Gracian,
A. Lee,
B. Daniele,
L. Antonuzzo,
A. Sangiovanni,
A. Gasbarrini,
M. Scartozzi,
M. Ahn,
S. Oh,
S. Orlov,
H. Harputluoglu,
B. Oksuzoglu,
Chiun Hsu,
K. Rau,
Oleksandr Krechkovskyi,
Vladimir Yareshko,
H. Xiong,
F. Lee,
Yixing Jiang,
A. Gabayan,
Mary Crow,
C. Steenkiste,
G. Verset
|
7 |
2023 |
7
🐜
|
|
🐜
|
Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.
19 auth.
Chun-Jen Liu,
W. Chuang,
Chuan‐Mo Lee,
Ming‐Lung Yu,
Sheng-Nan Lu,
Shun‐Sheng Wu,
L. Liao,
Chi-Ling Chen,
H. Kuo,
Y. Chao,
...
S. Tung,
Sien‐Sing Yang,
J. Kao,
Chen‐Hua Liu,
W. Su,
Chih‐Lin Lin,
Y. Jeng,
Pei‐Jer Chen,
Ding‐Shinn Chen
|
7 |
2009 |
7
🐜
|
|
🐜
|
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
28 auth.
T. Su,
Tsung‐Hui Hu,
Chi-yi Chen,
Yi‐Hsiang Huang,
W. Chuang,
Chun-Che Lin,
Chia-Chi Wang,
W. Su,
Ming‐Yao Chen,
C. Peng,
R. Chien,
Yi-Wen Huang,
Horng‐Yuan Wang,
Chih‐Lin Lin,
Sheng-Shun Yang,
...
Tsung-Ming Chen,
L. Mo,
Shih-Jer Hsu,
K. Tseng,
T. Hsieh,
F. Suk,
Chi-Tan Hu,
Ming-Jong Bair,
Cheng‐Chao Liang,
Y. Lei,
T. Tseng,
Chi-Ling Chen,
J. Kao
|
7 |
2016 |
7
🐜
|
|
🐜
|
Disturbance of circadian gene expression in hepatocellular carcinoma
8 auth.
Yueh-min Lin,
J. Chang,
K. Yeh,
Ming-Yu Yang,
Ta‐Chih Liu,
Sheng-fung Lin,
...
W. Su,
Jan-Gowth Chang
|
7 |
2008 |
7
🐜
|
|
🐜
|
Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in Taiwan
14 auth.
Sheng-Nan Lu,
W. Su,
Sheng-Shun Yang,
Ting Chang,
K. Cheng,
Jaw‐Ching Wu,
H. Lin,
Shun‐Sheng Wu,
Chuan‐Mo Lee,
C. Changchien,
...
Chien-Jen Chen,
J. Sheu,
Ding‐Shinn Chen,
Chien-Hung Chen
|
7 |
2006 |
7
🐜
|
|
🦁
|
Glaucoma is associated with peripheral vascular endothelial dysfunction.
W. Su,
Shih-Tsung Cheng,
W. Ho,
P. Tsay,
Shiu-Chen Wu,
Shirley H. L. Chang
|
6 |
2008 |
6
🦁
|
|
🐢
|
Modification of different molecular weights of chitosan by p-Coumaric acid: Preparation, characterization and effect of molecular weight on its water solubility and antioxidant property.
P. Panda,
Jen-Ming Yang,
Yen-Hsiang Chang,
W. Su
|
6 |
2019 |
6
🐢
|
|
🐜
|
Evaluation of Abdominal Ultrasonography Mass Screening for Hepatocellular Carcinoma in Taiwan
14 auth.
Y. Yeh,
Tsung‐Hui Hu,
Po-Yuan Cho,
Hsiu-Hsi Chen,
A. Yen,
S. Chen,
S. Chiu,
J. Fann,
W. Su,
Yi-Jen Fang,
...
Shih-Tien Chen,
Hsiao-Ching San,
Hung-Pin Chen,
C. Liao
|
6 |
2014 |
6
🐜
|
|
🐜
|
Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients
13 auth.
Chien-Hung Chen,
Ting Chang,
K. Cheng,
W. Su,
Sheng-Shun Yang,
H. Lin,
Shun‐Sheng Wu,
Chuan‐Mo Lee,
C. Changchien,
Chien-Jen Chen,
...
J. Sheu,
Ding‐Shinn Chen,
Sheng-Nan Lu
|
6 |
2006 |
6
🐜
|
|
🐜
|
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow‐up
19 auth.
Ming‐Lung Yu,
Chuan‐Mo Lee,
Chi-Ling Chen,
W. Chuang,
Sheng-Nan Lu,
Chen‐Hua Liu,
Shun‐Sheng Wu,
L. Liao,
H. Kuo,
Y. Chao,
...
S. Tung,
Sien‐Sing Yang,
J. Kao,
W. Su,
Chih‐Lin Lin,
Hung‐Chih Yang,
Pei‐Jer Chen,
Ding‐Shinn Chen,
Chun-Jen Liu
|
6 |
2013 |
6
🐜
|
